Skip to main content
Clinical Trials/RBR-83pwm3
RBR-83pwm3
Recruiting
未知

The effect of the aerobic exercise associated to the constraint-induced movement therapy in chronic hemiparetic individuals: a randomized clinical trial

niversidade Federal de São Carlos0 sitesMay 7, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic hemiparetic individuals post Stroke
Sponsor
niversidade Federal de São Carlos
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 7, 2018
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade Federal de São Carlos

Eligibility Criteria

Inclusion Criteria

  • Chronic Hemiparetic individuals (more than 6 months) what the vascular accident involved the same hemisphere with lesions restricted to the middle and anterior vascular, report of the imaging test; 18 and 80 years; present a minimum active movement of 45° of shoulder flexion and abduction, 20° of elbow extension, 10° of wrist extension, 10° of abduction or extension of the thumb, and 10° extension in at least two fingers (metacarpophalangeal and interphalangeal joints) and thumb; present asymmetry in the use of the upper limbs with score 2\.5 in the Motor Activity Log (MAL) Quantity Scale; ability to remain in a seated position without support for the trunk and/or of the arms for one minute

Exclusion Criteria

  • Individuals with cognitive deficits; smokers; alcohol; users of illicit drugs; with structural abnormalities in the cardiovascular and respiratory systems, uncorrected auditory and visual deficits, abnormalities on the electrocardiogram such as ischemic changes, arrhythmias, conduction disorders at rest and/or during the clinical exercise test; diseases or osteomiarticular alterations that affect the data collection or generate pain during the activities; obese (Body Mass Index more than 28 kg/ m2\); diabetes mellitus and uncontrolled hypertension; comprehension aphasia; apraxia; stroke bilateral or acute or subacute stroke (less than 6 months) or transient vascular accident and other the central and peripheral nervous system diseases; who are participating in other experimental or rehabilitation studies; who have had botulinum toxin application in the last three months prior to evaluation will be not included

Outcomes

Primary Outcomes

Not specified

Similar Trials